Effects of Quince Gel and Hesperidin Mixture on Experimental Endometriosis
Quince gel and hesperidin treatment restored uterine tissue and antioxidant status in an experimental endometriosis model by decreasing inflammation, cell death, and improving organelles.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (59)
- Anti-TNF-α treatment for pelvic pain associated with endometriosis via openalex
- Biomarkers for Endometriosis via openalex
- Endometriosis: Epidemiology, Diagnosis and Clinical Management via openalex
- Endometriosis: Three-year histopathological perspective from the largest hospital in Africa via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Molecular and Cellular Pathogenesis of Endometriosis via openalex
- Pathogenesis of Endometriosis: The Role of Peritoneal Fluid via openalex
- Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-α in women with endometriosis via openalex
- Theories of endometriosis via openalex
- Theories on the Pathogenesis of Endometriosis via openalex
- The Role of Serum Caspase 3 Levels in Prediction of Endometriosis Severity via openalex
- [TNF-alpha serum levels in women with endometriosis: prospective clinical study]. via openalex
- W2052289997 via openalex
- W2062693318 via openalex
- W2064443423 via openalex
- W2069564454 via openalex
- W2070032192 via openalex
- W2310813452 via openalex
- W2321031165 via openalex
- W2325707043 via openalex
- W2346020725 via openalex
- W2611423015 via openalex
- W2620241325 via openalex
- W2889140275 via openalex
- W2980603507 via openalex
- W2995298233 via openalex
- W3000079315 via openalex
- W3016339115 via openalex
- W3037094957 via openalex
- W3091915012 via openalex
- W3171259933 via openalex
- W3194419458 via openalex
- W3202177173 via openalex
- W4282595930 via openalex
- W4295067559 via openalex
- W4310787324 via openalex
- W4323294624 via openalex
- W4361280499 via openalex
- W6629980884 via openalex
- W6647786800 via openalex
- W6661376251 via openalex
- W6714120004 via openalex
- W6779966242 via openalex
- W6796891428 via openalex
- W6842772888 via openalex
- W6847762596 via openalex
- W133837954 via openalex
- W6850333471 via openalex
- W1736515909 via openalex
- W1745634660 via openalex
- W1970681737 via openalex
- W1990065094 via openalex
- W2000189967 via openalex
- W2030220088 via openalex
- W2035245477 via openalex
- W2038519052 via openalex
- W2038532930 via openalex
- W2042642675 via openalex
- W2047091819 via openalex
Cited by (2)
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Heterologous): heterologous rodent models 2025
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-04T00:33:33.688715+00:00